
The European Commission has published a Commission Staff Working Document summarizing the results of an evaluation of the State aid rules adopted as part of the State Aid Modernisation package. The evaluation concludes that, overall, the State aid control system and rules are fit for purpose. However, individual rules will need some adaptation, also in the light of the recent European Green Deal and the EU’s Industrial and Digital Strategies.
As part of the Commission’s ongoing review of competition rules to ensure they are fit for the changing market environment, the evaluation of the State aid rules was launched in January 2019. The assessment took the form of a “fitness check”, involving internal analyses by the Commission and public consultations as well as, in some cases, studies prepared by external consultants or targeted consultations of specific stakeholders. The exercise covered the following rules, which were adopted as part of the State Aid Modernisation:
- General Block Exemption Regulation (GBER)
- De minimis Regulation
- Guidelines on regional State aid
- Framework for State aid for research and development and innovation (RDI)
- Communication on important projects of common European interest (IPCEI)
- Guidelines on State aid to promote risk finance investments
- Guidelines on State aid to airports and airlines
- Guidelines on State aid for environmental protection and energy
- Guidelines on State aid for rescuing and restructuring
In addition, it also covered the Railways Guidelines from 2008 and the Short term export credit Communication from 2012. Those rules were not revised as part of the State Aid Modernisation, but an evaluation was relevant in the light of developments in EU law and the Commission’s case practice.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas